A staged screening protocol identifies people with biomarkers related to neuronal alpha-synuclein disease
Ethan G. Brown, Lana M. Chahine, Andrew Siderowf, Caroline Gochanour, Ryan Kurth, Micah J. Marshall, Chelsea Caspell-Garcia, Michael C. Brumm, Christopher S. Coffey, Craig E. Stanley Jr., Monica Korell, Bridget McMahon, Maggie Kuhl, Kimberly Fabrizio, Laura Heathers, Tatiana M. Foroud, Luis Concha-Marambio, Claudio Soto, Sohini Chowdhury, Tanya Simuni, Kenneth Marek, Caroline M. Tanner, the Parkinson Progression Marker Initiative
doi: https://doi.org/10.1101/2024.06.03.24308229
Ethan G. Brown
1Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA
MDLana M. Chahine
2Department of Neurology, University of Pittsburgh, Pittsburgh, PA, USA
MDAndrew Siderowf
3Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
MDCaroline Gochanour
4Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA, USA
MSRyan Kurth
4Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA, USA
MSMicah J. Marshall
4Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA, USA
MSChelsea Caspell-Garcia
4Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA, USA
MSMichael C. Brumm
4Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA, USA
MSChristopher S. Coffey
4Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA, USA
PhDCraig E. Stanley Jr.
5Institute for Neurodegenerative Disorders, New Haven, CT, USA
PhDMonica Korell
1Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA
MPHBridget McMahon
5Institute for Neurodegenerative Disorders, New Haven, CT, USA
BSMaggie Kuhl
6The Michael J. Fox Foundation, New York, NY, USA
BAKimberly Fabrizio
5Institute for Neurodegenerative Disorders, New Haven, CT, USA
BALaura Heathers
7Department of Medical and Molecular Genetics, Indiana University, Indianapolis, IN, USA
BATatiana M. Foroud
7Department of Medical and Molecular Genetics, Indiana University, Indianapolis, IN, USA
Luis Concha-Marambio
8Amprion, San Diego, CA, USA
PhDClaudio Soto
8Amprion, San Diego, CA, USA
9Department of Neurology, University of Texas McGovern Medical School at Houston, Houston, TX, USA
PhDSohini Chowdhury
6The Michael J. Fox Foundation, New York, NY, USA
MATanya Simuni
10Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
MDKenneth Marek
5Institute for Neurodegenerative Disorders, New Haven, CT, USA
MDCaroline M. Tanner
1Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA
PhDArticle usage
Posted June 04, 2024.
A staged screening protocol identifies people with biomarkers related to neuronal alpha-synuclein disease
Ethan G. Brown, Lana M. Chahine, Andrew Siderowf, Caroline Gochanour, Ryan Kurth, Micah J. Marshall, Chelsea Caspell-Garcia, Michael C. Brumm, Christopher S. Coffey, Craig E. Stanley Jr., Monica Korell, Bridget McMahon, Maggie Kuhl, Kimberly Fabrizio, Laura Heathers, Tatiana M. Foroud, Luis Concha-Marambio, Claudio Soto, Sohini Chowdhury, Tanya Simuni, Kenneth Marek, Caroline M. Tanner, the Parkinson Progression Marker Initiative
medRxiv 2024.06.03.24308229; doi: https://doi.org/10.1101/2024.06.03.24308229
A staged screening protocol identifies people with biomarkers related to neuronal alpha-synuclein disease
Ethan G. Brown, Lana M. Chahine, Andrew Siderowf, Caroline Gochanour, Ryan Kurth, Micah J. Marshall, Chelsea Caspell-Garcia, Michael C. Brumm, Christopher S. Coffey, Craig E. Stanley Jr., Monica Korell, Bridget McMahon, Maggie Kuhl, Kimberly Fabrizio, Laura Heathers, Tatiana M. Foroud, Luis Concha-Marambio, Claudio Soto, Sohini Chowdhury, Tanya Simuni, Kenneth Marek, Caroline M. Tanner, the Parkinson Progression Marker Initiative
medRxiv 2024.06.03.24308229; doi: https://doi.org/10.1101/2024.06.03.24308229
Subject Area
Subject Areas
- Addiction Medicine (382)
- Allergy and Immunology (699)
- Anesthesia (190)
- Cardiovascular Medicine (2837)
- Dermatology (243)
- Emergency Medicine (427)
- Epidemiology (12545)
- Forensic Medicine (10)
- Gastroenterology (801)
- Genetic and Genomic Medicine (4419)
- Geriatric Medicine (401)
- Health Economics (712)
- Health Informatics (2845)
- Health Policy (1046)
- Hematology (373)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (461)
- Neurology (4173)
- Nursing (220)
- Nutrition (615)
- Oncology (2199)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (317)
- Pain Medicine (266)
- Palliative Medicine (81)
- Pathology (485)
- Pediatrics (1171)
- Primary Care Research (482)
- Public and Global Health (6764)
- Radiology and Imaging (1487)
- Respiratory Medicine (897)
- Rheumatology (430)
- Sports Medicine (368)
- Surgery (472)
- Toxicology (57)
- Transplantation (200)
- Urology (173)